29.04.2014 Views

Genetic screening: ethical issues - Nuffield Council on Bioethics

Genetic screening: ethical issues - Nuffield Council on Bioethics

Genetic screening: ethical issues - Nuffield Council on Bioethics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

108<br />

C<strong>on</strong>genital hypothyroidism<br />

Mode of inheritance : usually not inherited - about 5-10% of cases due to a<br />

known genetic defect<br />

Abnormal development or functi<strong>on</strong> of the thyroid gland resulting in lack of producti<strong>on</strong><br />

of thyroid horm<strong>on</strong>e (thyroxine) occurs in about 1 in 4,000 babies in the UK. The baby<br />

is usually normal at birth because the mother’s thyroxine has been able to pass to the<br />

baby. Unless treatment with thyroxine is started within the first few weeks of life,<br />

growth and mental development will be delayed. Screening is carried out by measuring<br />

specific horm<strong>on</strong>es in the blood taken from the baby at around the end of the first week<br />

(the same blood sample as used for PKU - see later).<br />

Cystic fibrosis<br />

Mode of inheritance : recessive<br />

Cystic fibrosis (CF) is a serious inherited disease affecting the lungs and digestive<br />

system of babies, children and young adults. People with CF have sticky mucus in<br />

their lungs and are particularly pr<strong>on</strong>e to chest infecti<strong>on</strong>s. They also have difficulty in<br />

digesting foods, especially fatty foods, and may later develop liver problems.<br />

Treatment (antibiotics, physiotherapy, digestive enzymes) can greatly help but does not<br />

cure the c<strong>on</strong>diti<strong>on</strong>. The average life expectancy for a pers<strong>on</strong> with CF is about 20-30<br />

years. The disorder is inherited and the change in the gene resp<strong>on</strong>sible for about 85%<br />

of the cases can now be detected. For the disease to develop, a defective gene must<br />

be inherited from each parent. Parents who have <strong>on</strong>ly <strong>on</strong>e of a pair of defective genes<br />

are known as carriers and are themselves completely healthy. About 1 in 20 of the<br />

white populati<strong>on</strong> in the UK are carriers of the gene; the disease occurs in about 1 in<br />

2,000 babies born. If both parents are carriers, the risk of any baby having the disease<br />

is 1 in 4.<br />

Down’s syndrome<br />

Mode of inheritance : usually not inherited<br />

The disorder, which is genetic but usually not inherited, affects about 1 in 600 babies<br />

born overall, although the risk of having a child with Down’s syndrome rises sharply<br />

when the mother is over 35 years of age.<br />

The vast majority of individuals with Down’s syndrome have an extra copy of<br />

chromosome 21, are born with specific physical characteristics and have severe<br />

learning disabilities. A very small percentage are inherited due to a translocati<strong>on</strong>.<br />

Duchenne muscular dystrophy (DMD)<br />

Mode of inheritance : X-linked<br />

Duchenne muscular dystrophy is a serious progressive disease of muscles affecting<br />

about <strong>on</strong>e in 3,500 newborn boys. There are no signs of disease at birth, and affected<br />

boys develop and grow normally until around 18 m<strong>on</strong>ths of age. From the ages of 7<br />

to 12, affected boys become wheelchair bound. Death from chest infecti<strong>on</strong> or heart<br />

failure usually occurs by the early 20s or before.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!